NEW YORK, Jan. 20, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

Tech Data Corporation (NASDAQ: TECD)
The investigation concerns whether Tech Data and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Tech Data to an affiliate of funds managed by affiliates of Apollo Global Management, Inc. for $145.00 per share. If you are a Tech Data shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/tech-data-corporation-tecd-stock-merger-apollo/.

TD Ameritrade Holding Corporation (NASDAQ: AMTD)
The investigation concerns whether TD Ameritrade and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of TD Ameritrade to The Charles Schwab Corporation for 1.0837 Charles Schwab shares for each TD Ameritrade share. If you are a TD Ameritrade shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/td-ameritrade-holding-corporation-amtd-stock-merger-charles-schwab/.

Wright Medical Group N.V. (NASDAQ: WMGI)
The investigation concerns whether Wright Medical and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Wright Medical to Stryker Corporation for $30.75 per share. If you are a Wright Medical shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/wright-medical-group-nv-stock-merger-stryker-corporation/.

Neon Therapeutics, Inc. (NASDAQ: NTGN)
The investigation concerns whether Neon and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Neon to BioNTech SE for 0.063 American Depositary Shares of BioNTech for each share of Neon. If you are a Neon shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/neon-therapeutics-inc-ntgn-stock-merger-biontech/.

On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.